Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and anitbody titres than know commercial vaccines.
Type:
Grant
Filed:
November 3, 2003
Date of Patent:
May 31, 2005
Assignee:
SmithKline Beecham Biologicals, s.a.
Inventors:
Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez